Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04503109 · ClinicalTrials.gov registry record · NA
Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System
A NA study, sponsored by Nalu Medical.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT04503109 is a NA study that has completed, run by Nalu Medical. The registered enrollment target is 110 participants.
The verdict
NCT04503109, a NA study, has completed, sponsored by Nalu Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The Nalu Neurostimulation System is capable of delivering multiple therapy options to address patient needs. The study will confirm the efficacy, safety, comfort and compliance with the Nalu Neurostimulation System in adult subjects with chronic pain in the legs and back. Patients who have been diagnosed with failed back surgery syndrome (FBSS) and meet other study eligibility criteria will be enrolled in the study to receive the Nalu Neurostimulation System.
Interventions
- DEVICE Nalu Neurostimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-07-16 |
| Est. Completion | 2022-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04503109
The ClinicalTrials.gov registry entry for NCT04503109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nalu Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nalu Neurostimulation System is the first listed.
NCT04503109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04503109 about?
NCT04503109 is a clinical study titled "Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System". The Nalu Neurostimulation System is capable of delivering multiple therapy options to address patient needs. The study will confirm the efficacy, safety, comfort and compliance with the Nalu Neurostimulation System in adult subjects with chronic pain in the legs and back. Patients who have been diag...
What is the current status of trial NCT04503109?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2020-07-16. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT04503109?
The interventions under investigation include: Nalu Neurostimulation System (DEVICE).
Who is sponsoring clinical trial NCT04503109?
This trial is sponsored by Nalu Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.